Bio-IT World Venture, Innovation & Partnering

Connect Capital and Science to Shape the Future

May 19, 2026

As part of the 25th Annual Bio-IT World Conference & Expo, the 3rd Annual Bio-IT World Venture, Innovation & Partnering Conference (May 19, 2026) delivers an executive-level platform for investors, corporate leaders, and entrepreneurs driving the next wave of biotech and precision medicine. This boutique event convenes C-suite leaders from venture capital, private equity, corporate venture arms, growth-stage companies, and pharma. The 2026 program zeroes in on AI-driven discovery, platform- vs. product-investment models, evolving M&A and partnership strategies, IPO and private liquidity pathways, and regulatory shifts shaping capital deployment. Sessions are designed to provide investors with clear insights into market dynamics, risk-adjusted returns, and scalable innovation strategies. Through candid discussions, fireside chats, and curated panels, participants will explore how capital is being allocated, where innovation pipelines are headed, and how to identify long-term winners. Alongside investor-focused dialogue, attendees gain access to 150+ exhibits, 11 scientific tracks, and global partners from 30+ countries to broaden their market perspective.

Coverage will include, but is not limited to:

Tech VCs: From Software Playbooks to Biotech Breakthroughs
Beyond Mega Rounds: Creative Financing in a Shifting Capital Market
AI/ML to Generative Models: What Investors Need to Know in 2026
Deal-Making in the Age of Platforms: Rethinking M&A and Strategic Partnerships
IPO Windows, SPAC Fallout, and Private Liquidity: What’s Next for Biotech Exits
De-Risking Portfolios with Tech-Enabled Pharma Partnerships
Designing the 2026 Biotech Startup: Platform vs. Product and the Capital Pathway
Fundraising in a Reset Market: Aligning Valuations and Exit Timeline
Crossing the Valley of Death with Automation and AI-Driven Discovery
Next-Gen Regulation: Digital Endpoints, AI Oversight & Global Alignment

If you have a compelling story to share with innovators, investors, and executives attending this boutique event, we encourage you to submit a speaking proposal.

Please note that the vast majority of speakers are identified, selected, and invited by our summit chairs and advisory board members. As we receive a high volume of submissions, we regret that Cambridge VIP can only be in contact with those deemed optimal candidates.

To become a sponsor, click here.

SPEAKER PROPOSALS NOW BEING ACCEPTED

CONFERENCE CONTENT
Eileen Murphy, MEd
Conference Producer
781-738-0049
emurphy@healthtech.com

PARTNERING & SPONSORSHIP
Brian Caine
Manager, Strategic Partnerships
Venture, Innovation & Partnering (VIP) Event Series
908-809-0946
bcaine@healthtech.com